Annual EBITDA
-$2.35 M
+$2.86 M+54.86%
31 March 2024
Summary:
China SXT Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization is currently -$2.35 million, with the most recent change of +$2.86 million (+54.86%) on 31 March 2024. During the last 3 years, it has fallen by -$499.30 thousand (-26.96%). SXTC annual EBITDA is now -220.54% below its all-time high of $1.95 million, reached on 31 March 2019.SXTC EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SXTC EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +54.9% | - | - |
| 3 y3 years | -27.0% | - | - |
| 5 y5 years | -220.5% | - | - |
SXTC EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -27.0% | +54.9% | ||||
| 5 y | 5 years | -220.5% | +54.9% | ||||
| alltime | all time | -220.5% | +54.9% |
China SXT Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | -$2.35 M(-54.9%) | - | - |
| Mar 2023 | -$5.21 M(+3.1%) | - | - |
| Mar 2022 | -$5.05 M(+172.8%) | - | - |
| Mar 2021 | -$1.85 M(+83.5%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | -$1.01 M(-151.7%) | - | - |
| Mar 2019 | $1.95 M(+10.7%) | - | - |
| Mar 2018 | $1.76 M(+3.5%) | - | - |
| Mar 2017 | $1.70 M | - | - |
FAQ
- What is China SXT Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for China SXT Pharmaceuticals?
- What is China SXT Pharmaceuticals annual EBITDA year-on-year change?
What is China SXT Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of SXTC is -$2.35 M
What is the all time high annual EBITDA for China SXT Pharmaceuticals?
China SXT Pharmaceuticals all-time high annual earnings before interest, taxes, depreciation & amortization is $1.95 M
What is China SXT Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, SXTC annual earnings before interest, taxes, depreciation & amortization has changed by +$2.86 M (+54.86%)